Live Breaking News & Updates on Acute Cannabinoid Overdose

Stay updated with breaking news from Acute cannabinoid overdose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Indivior PLC Announcements | Indivior PLC: Indivior To Acquire Opiant Pharmaceuticals

Investegate announcements from Indivior PLC, Indivior To Acquire Opiant Pharmaceuticals ....

United States , United Kingdom , Mark Crossley , Tim Owens , Jason Thompson , Jennifer Ginther , Kathryn Hudson , National Institute On Drug Abuse , Emergent Biosolutions Inc , Opiant Pharmaceuticals Inc , Committee On Foreign Investment , Company Secretary , Health Systems , Tulchan Communications , Development Agency , Centers For Disease , National Institutes Of Health , Latham Watkins , Indivior To Acquire Opiant Pharmaceuticals , Covington Burling , Extends Indivior , Pipeline Anchored , Opioid Overdose Treatment , Confront Illicit Synthetic Opioids Like , Second Full Year , Host Investor Call ,

Indivior To Acquire Opiant Pharmaceuticals

/PRNewswire/ Indivior PLC (LON: INDV) ("Indivior" or the "Company") and Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) ("Opiant") today announced that the. ....

United States , Mark Crossley , Kathryn Hudson , Centers For Disease , Development Agency , National Institute On Drug Abuse , National Institutes Of Health , Emergent Biosolutions Inc , Latham Watkins , Opiant Pharmaceuticals Inc , Committee On Foreign Investment , Covington Burling , Company Secretary , Health Systems , Prnewswire Indivior , Acquisition Strengthens , Extends Indivior , Pipeline Anchored , Opioid Overdose Treatment , Confront Illicit Synthetic Opioids Like Fentanyl , Second Full Year , Host Investor Call , Opiant Pharmaceuticals , Chief Executive Officer , Roger Crystal , Chief Executive ,

Opiant Pharmaceuticals . OPNT Stock Price, News, Charts

Opiant Pharmaceuticals . OPNT Stock Price, News, Charts
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Opiant Pharmaceuticals Inc , Nasal Spray , Opioid Overdose Reversal , Alcohol Use Disorder , Opioid Use Disorder , Acute Cannabinoid Overdose , நாசி தெளிப்பு , ஓபியாய்டு ஓவர்‌டோஸ் தலைகீழ் , ஆல்கஹால் பயன்பாடு கோளாறு , ஓபியாய்டு பயன்பாடு கோளாறு , எடுப்போசை கன்னாபினாய்டு ஓவர்‌டோஸ் ,

OPNET Technologies Inc. (NASDAQ:OPNT) - Opiant Pharmaceuticals: Q1 Earnings Insights

Company s 52-week low was at $6.79
Price action over last quarter: down 6.20%
Company Overview
Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. The company s pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD) and Acute Cannabinoid Overdose (ACO). The majority of the revenue is generated in the form of Royalty and licensing.
....

Company Overview , Opiant Pharmaceuticals Inc , Opiant Pharmaceuticals Says Based On , Opiant Pharmaceuticals , Continues To See , Pharmaceuticals Inc , Nasal Spray , Opioid Overdose Reversal , Alcohol Use Disorder , Opioid Use Disorder , Acute Cannabinoid Overdose , நிறுவனம் ஓவர்‌வ்யூ , மருந்துகள் இன்க் , நாசி தெளிப்பு , ஓபியாய்டு ஓவர்‌டோஸ் தலைகீழ் , ஆல்கஹால் பயன்பாடு கோளாறு , ஓபியாய்டு பயன்பாடு கோளாறு , எடுப்போசை கன்னாபினாய்டு ஓவர்‌டோஸ் ,

OPNET Technologies Inc. (NASDAQ:OPNT) - Recap: Opiant Pharmaceuticals Q4 Earnings

52-week low: $6.79
Company Overview
Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. The company s pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD) and Acute Cannabinoid Overdose (ACO). The majority of the revenue is generated in the form of Royalty and licensing.

Related Articles (OPNT) ....

Company Overview , Opiant Pharmaceuticals Inc , Opiant Pharmaceuticals , Pharmaceuticals Inc , Nasal Spray , Opioid Overdose Reversal , Alcohol Use Disorder , Opioid Use Disorder , Acute Cannabinoid Overdose , நிறுவனம் ஓவர்‌வ்யூ , மருந்துகள் இன்க் , நாசி தெளிப்பு , ஓபியாய்டு ஓவர்‌டோஸ் தலைகீழ் , ஆல்கஹால் பயன்பாடு கோளாறு , ஓபியாய்டு பயன்பாடு கோளாறு , எடுப்போசை கன்னாபினாய்டு ஓவர்‌டோஸ் ,